Amanote Research

Amanote Research

    RegisterSign In

Update on the Clinical Use of Kinase Inhibitors in Melanoma

JDDG - Journal of the German Society of Dermatology - United Kingdom
doi 10.1111/ddg.13321
Full Text
Open PDF
Abstract

Available in full text

Categories
Dermatology
Date

September 1, 2017

Authors
Ioana CosgareaCathrin RitterJürgen C. BeckerDirk SchadendorfSelma Ugurel
Publisher

Wiley


Related search

Immune Checkpoint Inhibitors in Melanoma: Review and Update

Journal of the Portuguese Society of Dermatology and Venereology
2018English

The Specificities of Protein Kinase Inhibitors: An Update

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2003English

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

iScience
Multidisciplinary
2019English

Update on TNF Inhibitors

Seminars in Cutaneous Medicine and Surgery
DermatologyMedicineSurgery
2016English

Update on Adjuvant Melanoma Therapy

Current Opinion in Oncology
Cancer ResearchOncology
2018English

Update in Ocular Melanoma

2013English

An Update on BRAF Inhibitors and Other New Molecular Targets for the Treatment of Malignant Melanoma of the Skin

Clinical Medicine Insights: Dermatology
2013English

Posaconazole: An Update of Its Clinical Use

Pharmacy
2015English

BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy